APP and Alzheimer disease: The amyloid hypothesis of AD pathogenesis favors amyloid-β peptide (Aβ), a product of the sequential proteolytic cleavage of the transmembrane amyloid protein precursor (APP) by β-site APP-cleaving enzyme (β-secretase or BACE1) and γ-secretase, as a trigger for AD [19–22].